Sarilumab

From WikiMD's Wellness Encyclopedia

Information about Sarilumab[edit source]

Sarilumab is a human monoclonal IgG1 antibody to the interleukin-6 (IL-6) receptor which is used in the therapy of rheumatoid arthritis and other autoinflammatory conditions.


Liver safety of Sarilumab[edit source]

Sarilumab commonly causes mild serum aminotransferase elevations which are usually short lived and asymptomatic and has also been linked to rare instances of clinically apparent liver injury with jaundice.

Mechanism of action of Sarilumab[edit source]

Sarilumab (sar il' ue mab) is human IgG1 monoclonal antibody to the IL-6 receptor that is used largely as therapy of refractory rheumatoid arthritis. Sarilumab binds to both soluble and membrane bound IL-6 receptors and blocks IL-6 signaling. IL-6 is a key proinflammatory cytokine that mediates a wide spectrum of biologic activities including activation of T cells, differentiation of B cells, induction of acute phase reactants, proliferation of fibroblasts, and damage to cartilage and joints. IL-6 levels are elevated in patients with active rheumatoid arthritis. In controlled trials and open label studies, sarilumab therapy led to improvements in symptoms and laboratory abnormalities in patients with rheumatoid arthritis who had an inadequate response to other disease modifying antirheumatic drugs (DMARDs).

FDA approval information for Sarilumab[edit source]

Sarilumab was approved for use in the United States in 2017 for refractory rheumatoid arthritis. It is considered a DMARD, in that it improves signs and symptoms of disease and decreases cartilage and tissue destruction. Sarilumab is under evaluation in other inflammatory rheumatic diseases as well as other inflammatory autoimmune conditions, but has not been approved for these uses.

Dosage and administration for Sarilumab[edit source]

Sarilumab is given in doses of 200 mg by subcutaneous injection every 2 weeks either alone (monotherapy) or in combination with other conventional DMARDs. Sarilumab is available in single dose prefilled syringes of 150 and 200 mg in 1.14 mL under the brand name Kevzara.

Side effects of Sarilumab[edit source]

The most frequent side effects are upper respiratory symptoms, headache, infusion reactions and hypertension. Rare, potentially serious adverse events include serious infections, reactivation of tuberculosis and hypersensitivity reactions.

antirheumatic agents[edit source]

Sarilumab Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD